Condition
Human Papilloma Virus Infection Type 16 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Human Papilloma Virus Infection Type 16 clinical trials that are recruiting, at sites in 3 countries (most in Belgium (1), Taiwan (1), United States (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
PVX4 DNA vaccine for HPV16-positive high-grade cervical dysplasia
This trial will try a PVX4 DNA vaccine delivered by electroporation to clear HPV16 infection and shrink high-grade cervical dysplasia (CIN2/3) in people with biopsy-confirmed HPV16-positive disease.
-
Using first-void urine to observe how HPV16 antibodies interact with the virus before and after HPV vaccination
This trial will test whether giving two doses of Gardasil 9 to HPV16-positive women aged 18–45 reduces infectious virus in first-void urine and increases HPV-specific antibodies detectable in that urine.
Quick answers
How many Human Papilloma Virus Infection Type 16 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Belgium (1 trial), Taiwan (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.